RKO—the only colorectal cancer line we examined that was not sensitive to ATF6 knockdown (Supplementary Fig. S2I and S2N)—differs from the ATF6-dependent lines in that it lacks dysregulating mutations in the Wnt pathway (89). The gene discussed is ATF6; the disease is colorectal cancer.